Environmental allergens trigger type 2 inflammation through ripoptosome activation.

Area of Science:

• Immunology
• Cellular Biology
• Molecular Medicine

Background:

• Environmental allergens like fungi and mites trigger type 2 immunity.
• The precise innate sensing mechanisms and initial signaling events remain largely unknown.

Purpose of the Study:

• To elucidate the molecular mechanisms by which environmental allergens initiate type 2 immune responses in epithelial cells.
• To identify key signaling pathways and molecules involved in allergen sensing and subsequent inflammatory responses.

Main Methods:

• Investigated ripoptosome activation (RIPK1-caspase 8 complex) in epithelial cells upon allergen exposure.
• Assessed the role of caspase 8 in the intracellular maturation and release of IL-33.
• Utilized pharmacological inhibition of caspase 8 and gene deletion (Il33, Casp8) in murine models.
• Analyzed clinical data to correlate ripoptosome activation and IL-33 maturation with human allergic inflammation.

Main Results:

• Allergens were shown to trigger RIPK1-caspase 8 ripoptosome activation in epithelial cells.
• Active caspase 8 was found to mediate the maturation and release of the alarmin cytokine IL-33.
• Inhibition or deletion of caspase 8 and IL-33 significantly attenuated allergic inflammation in vivo.
• Clinical data supported the role of ripoptosome activation and IL-33 maturation in human allergic diseases.

Conclusions:

• The ripoptosome serves as a critical intracellular signaling platform for sensing environmental allergens in epithelial cells.
• This pathway culminates in IL-33 maturation and release, driving type 2 innate immune responses and allergic inflammation.
• Targeting the ripoptosome-IL-33 axis presents a promising therapeutic strategy for human allergic diseases.